Psöriazis vulgaris hastalarında nötrofil/lenfosit oranı, trombosit/lenfosit oranı, ortalama trombosit hacmi ve C-reaktif protein değerleri
Amaç: Son yıllarda nötrofil/lenfosit oranı (NLO), trombosit/lenfosit oranı (TLO),ortalama trombosit hacmi(OTH) ve C reaktif protein(CRP)’nin sistemik inflamasyonun önemli göstergeleri olduğu gösterilmiştir. Yapılan çalışmalarda psöriazis vulgaris hastalarında NLO, TLO, OTH ve CRP ’nin kontrol gurubuna göre daha yüksek olduğu gösterilmiştir. Çalışmamızda psöriazisli hastaların NLO, TLO, OTH ve CRP düzeyleri ölçüldü ve bu parametrelerin tırnak tutulumu, artrit varlığı, hastalık süresi ve PAŞİ skoru ile ilişkili olup olmadığı araştırıldı. Yöntemler: Herhangi bir sistemik hastalığı, infeksiyöz hastalığı ve otoimmun hastalığı olmayan 133 psöriazis vulgaris hastası ve 107 sağlıklı kontrol çalışmaya dahil edildi. Hastalar PAŞİ skoruna göre hafif (PAŞİ
Evaluation of neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, mean platelet volume, and C-reactive protein in patients with psoriasis vulgaris
Objective: Recent reports indicate that neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), mean platelet volume (MPV), and C-reactive protein (CRP) are key markers of systemic inflammation. These markers have also been shown to be significantly increased in patients with psoriasis vulgaris compared to control subjects. In this study, we aimed to evaluate the relationship between serum levels of NLR, PLR, MPV, and CRP and nail involvement, presence of arthritis, duration of disease, and Psoriasis Area and Severity Index (PASI) scores in patients with psoriasis vulgaris. Methods: The study included 133 patients with psoriasis vulgaris that had no systemic, infectious, or autoimmune diseases and a control group of 107 healthy volunteers. The patients were divided into two groups based on their PASI scores: (I) mild (PASI
___
- Beygi S, Lajevardi V, Abedini R. C-reactive protein in psoriasis: a review of the literatüre. JEADV. 2014; 28: 700-11.
- Coimbra S, Oliveira H, Reis F, et al. C-reactive protein and leucocyte activation in psoriasis vulgaris according to severity and therapy. J Eur Acad Dermatol Venereol. 2010; 24: 789–96
- Saleh HMA, Attia EAS, Onsy AM, Saad AA, Abd Ellah MMM. Platelet activation: a link between psoriasis per se and subclinical atherosclerosis - a case - control study. Br J Dermatol. 2013; 169: 68-75
- Sahpaz P,Ulutas KT. Assessment of mean platelet volume in type 2 diabetics receiving insulin or oral antidiabetic agents. Dicle Med J. 2015; 42: 399-403.
- Incebıyık A, Uyanıkoglu H. Is there a role mean platelet volume in the diagnosis of patients with adnexal torsion? Dicle Med J. 2017; 44: 333-7.
- Chu SG, Becker RC, Berger PB, et al. Mean platelet volume as a predictor of cardiovascular risk: a systematic review and meta-analysis. J Thromb Haemost. 2010; 8: 148-56.
- Yurtdas M, Yaylali YT, Kaya Y et al. Neutrophil-to-lymphocyte ratio may predict subclinical atherosclerosis in patients with psoriasis. Echocardiography. 2014; 31: 1095–104.
- Cerman AA, Karabay EA, Altunay IK. Evaluation of neutrophil-lymphocyte ratio and mean platelet volume in patients with psoriasis. SETB. 2016; 50: 137-41
- Ataseven A, Bilgin AU, Kurtipek GS. The importance of neutrophil lymphocyte ratio in patients with psoriasis. Clin Med Res. 2014; 3: 40–3.
- Yurtdaş M, Yaylali YT, Kaya Y, et al. Neutrophilto Lymphocyte Ratio May Predict Subclinical Atherosclerosis in Patients with Psoriasis. Echocardiography. 2014; 31: 1095-104.
- Kim DS, Shin D, Lee MS, et al. Assessments of neutrophil to lymphocyte ratio and platelet to lymphocyte ratio in Korean patients with psoriasis vulgaris and psoriatic arthritis. J Dermatol. 2016; 43: 305-10.
- Sengül E,Ozbay M, Topcu I. Relationship between Neutrophil-to-Lymphocyte Ratio and Prognosis in Patients with Deep Neck Space Infection. Dicle Med J. 2016; 43: 126-9.
- Gunabatar H, Ekin S, Sunnetcioglu H, et al. The relationship between neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in patients with obstructive sleep apnea syndrome. Dicle Med J. 2015; 42: 289-93.
- Cemil BC, Atas H. The Effect of Biological Treatment onto Systemic Inflammatory Markers and Plateletcrit in Psoriasis Patients. Dicle Med J. 2016; 43: 477-83.
- Balta S, Cakar M, Demirkol S, Arslan Z, Akhan M. Higher neutrophil to lymphocyte ratio in patients with metabolic syndrome. Clin Appl Thromb Hemost. 2013; 19: 579.
- Orem A, Deger O, Cimsit G, Bahadır S. Plasma polymorphonuclear leukocyte elastase levels and its relation to disease activity in psoriasis. Clin Chim Acta.1997; 264: 49-56.
- Sen BB, Rifaioglu EN, Ekiz O, Inan MU, Sen T, Sen N. Neutrophil to lymphocyte ratio as a measure of systemic inflammation in psoriasis. Cutan Ocul Toxicol. 2014; 33: 223-7.
- Rocha-Pereira P, Santos-Silva A, Rebelo I, Figueiredo A, Quintanilha A, Teixeira F. The inflammatory response in mild and in severe psoriasis. Br J Dermatol. 2004; 150: 917-28.
- Krueger G, Ellis CN. Psoriasis – recent advances in understanding its pathogenesis and treatment. J Am Acad Dermatol. 2005; 53: 94–100.
- Turkmen K, Erdur FM, Ozcicek F, et al. Platelet-tolymphocyte ratio better predicts inflammation than neutrophil-to-lymphocyte ratio in end-stage renal disease patients. Hemodial Int. 2013; 17: 391-6.
- Asahina A, Kubo N, Umezawa Y, Honda H, Yanaba K, Nakagawa H. Neutrophil–lymphocyte ratio, platelet– lymphocyte ratio and mean platelet volume in Japanese patients with psoriasis and psoriatic arthritis: Response to therapy with biologics. J Dermatol. 2017; 44: 1112-21
- Karabudak O, Ulusoy RE, Erikci AA, Solmazgul E, Dogan B,Harmanyeri Y. Inflammation and hypercoagulable state in adult psoriatic men. Acta Derm Venereol. 2008; 88: 337-40.
- Gaspari AA. Innate and adaptive immunity and the pathophysiology of psoriasis. J Am Acad Dermatol.2006; 54: 67-80.
- Unal M, Kucuk A, Unal GU, et al. Mean platelet volume, neutrophil to lyphocyte ratio and platelet to lymphocyte ratio in psoriasis. Turkderm. 2015; 49: 112-6.